eLife, 2024 · DOI: https://doi.org/10.7554/eLife.95672 · Published: November 15, 2024
This study investigates the role of different types of astrocytes in neuropathic pain following spinal cord injury (SCI). By selectively eliminating resident astrocytes in mice, the researchers aimed to understand if this could reduce SCI-induced neuropathic pain. The researchers used transgenic mice and viral vectors to target and eliminate resident astrocytes in the lumbar enlargement of the spinal cord. Pain-related behaviors were then measured using various methods to assess the impact of astrocyte elimination. The study found that eliminating resident astrocytes attenuated neuropathic pain and activated microglia, with the type I interferons (IFNs) signal significantly activated in microglia. This suggests that targeting type I IFNs signals could be an effective strategy for neuropathic pain treatment after SCI.
Type I IFNs signals may represent a novel therapeutic target for the treatment of neuropathic pain following SCI.
Targeting resident astrocytes specifically can reduce neuropathic pain.
Microglia activation and the type I IFN pathway are crucial in mediating pain relief after astrocyte elimination, offering insights into potential therapeutic mechanisms.